Key Points
- Federal Circuit issued precedential opinion in Hospira Inc. v. Fresenius Kabi USA, LLC that affirmed obviousness of a liquid drug patent claim, encouraging future patent challengers to raise the issue of...more
1/24/2020
/ Appeals ,
Claim Limitations ,
Extrinsic Evidence ,
Inherency ,
Obviousness ,
Orange Book ,
Patent Infringement ,
Patents ,
Pharmaceutical Patents ,
POSITA ,
Precedential Opinion ,
Prior Art
On March 23, the US Court of Appeals for the Federal Circuit issued a decision endorsing an exception to the estoppel provisions for inter partes review (IPR) under 35 U.S.C ยง 315(e). Shaw Industry Group, Inc. v. Automated...more